News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Recent reports of a 'clinical trial' assessing 'stem cells' for the treatment of AMD are wrong say the Japanese researchers trying to transform somatic cells into retinal pigment epithelium (RPE) cells for transplant.
A new genetically modified strain of E. Coli cells could create enough protein for downstream production without the need for the challenging endotoxin removal steps that are currently employed.
The UK Government has chosen Darlington in North East England as the site for the new National Biologics Manufacturing Centre.
Roche has added iron and phosphate to the list of metabolites BioPharmas can detect and quantify using its process analytics technology.
Bristol-Myers Squibb has selected Samsung Biologics to manufacture the antibody cancer drug Yervoy for markets outside the US.